The NCI PREVENT Cancer Preclinical Drug Development Program – NCI Division of Cancer Prevention
NCI Division of Cancer Prevention shared on LinkedIn:
“Application deadline Monday!
Are you someone actively looking for resources to bolster your research on cancer preventive agent development? The NCI PREVENT Cancer Preclinical Drug Development Program \(PREVENT\) is a peer-reviewed program that supports the preclinical development of innovative interventions and predictive biomarkers for cancer prevention and interception towards clinical applications in high-risk populations.
All interested researchers from academia, industry, non-profits, and government with innovative ideas in precision cancer prevention are encouraged to apply.
Deadline: Monday, July 8, 2024.
For more information on Program support, types of supported projects, and the application visit here.”